Silvia S. Jurisson

6.5k citations

154 papers · 5.1k indexed · 2 hit papers · h-index 36

Radiology, Nuclear Medicine and Imaging top 0.2%
Oncology top 2%
Materials Chemistry top 5%
Inorganic Chemistry top 1%
Organic Chemistry top 2%

Co-authors: John D. Lydon Timothy J. Hoffman Dangshe Ma Cathy S. Cutler Douglas E. Berning Wei Jia Heather M. Hennkens Thomas P. Quinn
Topics: Radiopharmaceutical Chemistry and Applications (101 papers)Medical Imaging Techniques and Applications (33 papers)Medical Imaging and Pathology Studies (26 papers)
Cited by: Radiology, Nuclear Medicine and Imaging Inorganic Chemistry Oncology
Journals: Chemical Reviews Proceedings of the National Academy of Sciences Journal of the American Chemical Society
Partner nations: United States India Greece

In The Last Decade

Silvia S. Jurisson

151 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Potential Technetium Small Molecule Radiopharmaceuticals

1999 517 citations Silvia S. Jurisson, John D. Lydon profile →
Coordination compounds in nuclear medicine

1993 482 citations Silvia S. Jurisson, Dangshe Ma et al. profile →

Peers

Countries citing papers authored by Silvia S. Jurisson

Since Specialization

Citations

This map shows the geographic impact of Silvia S. Jurisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia S. Jurisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia S. Jurisson more than expected).

Fields of papers citing papers by Silvia S. Jurisson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia S. Jurisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia S. Jurisson. The network helps show where Silvia S. Jurisson may publish in the future.

Co-authorship network of co-authors of Silvia S. Jurisson

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia S. Jurisson. A scholar is included among the top collaborators of Silvia S. Jurisson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia S. Jurisson. Silvia S. Jurisson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Production and purification of research scale ¹⁶¹Tb using cation-exchange semi-preparative HPLC for radiopharmaceutical applications 2025 ·Radiochimica Acta ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Dmitri Medvedev,Cathy S. Cutler,D. Scott Wilbur,Yawen Li,Carolyn J. Anderson,Silvia S. Jurisson,Heather M. Hennkens	0
2	Direct labeling of a somatostatin receptor antagonist via peptide cyclization with Re, 99mTc and 186Re metal centers: Radiochemistry and in vitro evaluation 2021 ·Nuclear Medicine and Biology ·Jing Wang,George Makris,(unknown),(unknown),Fabio Gallazzi,Michael R. Lewis,Silvia S. Jurisson,Heather M. Hennkens	6
3	Recovery, recycling and re-irradiation of enriched 104Ru metal targets for cost effective production of 105Rh 2021 ·Applied Radiation and Isotopes ·(unknown),Tim E. Phelps,(unknown),(unknown),(unknown),John D. Lydon,(unknown),James Guthrie,Steven P. Kelley,Charles L. Barnes,Alan R. Ketring,Heather M. Hennkens,Silvia S. Jurisson	2
4	<p>Development of resveratrol-conjugated gold nanoparticles: interrelationship of increased resveratrol corona on anti-tumor efficacy against breast, pancreatic and prostate cancers</p> 2019 ·International Journal of Nanomedicine ·Velaphi C. Thipe,(unknown),(unknown),(unknown),Menka Khoobchandani,Kavita Katti,Silvia S. Jurisson,Kattesh V. Katti	95
5	Evaluation of 72Se/72As generator and production of 72Se for supplying 72As as a potential PET imaging radionuclide 2018 ·Applied Radiation and Isotopes ·Yutian Feng,(unknown),Tim E. Phelps,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),D. Scott Wilbur,Timothy J. Hoffman,Cathy S. Cutler,Alan R. Ketring,Silvia S. Jurisson	10
6	In vivo transport of three radioactive [18F]-fluorinated deoxysucrose analogs by the maize sucrose transporter ZmSUT1 2017 ·Plant Physiology and Biochemistry ·Thu M. Tran,(unknown),(unknown),Michael Harmata,J. David Robertson,Silvia S. Jurisson,David Braun	19
7	Synthesis and evaluation of a 99mTc tricarbonyl-labeled somatostatin receptor-targeting antagonist peptide for imaging of neuroendocrine tumors 2016 ·Nuclear Medicine and Biology ·(unknown),Fabio Gallazzi,Lisa Watkinson,Terry Carmack,(unknown),Michael R. Lewis,Silvia S. Jurisson,Dionysia Papagiannopoulou,Heather M. Hennkens	18
8	Deuteron irradiation of W and WO3 for production of high specific activity 186Re: Challenges associated with thick target preparation 2016 ·Applied Radiation and Isotopes ·(unknown),Katherine Gagnon,(unknown),Bennett E. Smith,(unknown),(unknown),Peter J. Pauzauskie,Michael E. Fassbender,Cathy S. Cutler,Alan R. Ketring,Silvia S. Jurisson,D. Scott Wilbur	15
9	Novel rhenium(iii, iv, and v) tetradentate N2O2 Schiff base mononuclear and dinuclear complexes 2013 ·Dalton Transactions ·(unknown),(unknown),(unknown),(unknown),Charles L. Barnes,Silvia S. Jurisson	15
10	Selenium-72 formation via natBr(p,x) induced by 100MeV Protons: Steps towards a novel 72Se/72As generator system 2012 ·Applied Radiation and Isotopes ·B. Ballard,(unknown),Eva R. Birnbaum,Kevin D. John,J.W. Lenz,Silvia S. Jurisson,C. Cutler,F.M. Nortier,W. A. Taylor,Michael E. Fassbender	35
11	Preparation and use of 198Au/199Au for potential applications in cancer therapy and imaging 2010 ·Transactions of the American Nuclear Society ·Cathy Cutler,Para Kan,Nripen Chanda,Silvia S. Jurisson,Lisa Watkinson,John R. Lever,Jeffrey C. Smith,Kattesh V. Katti,(unknown)	2
12	The complexation of rhodium(iii) with acyclic diaminedithioether (DADTE) ligands 2010 ·Dalton Transactions ·(unknown),H.P. Engelbrecht,(unknown),Charles L. Barnes,Cathy Cutler,Silvia S. Jurisson,Susan Z. Lever	6
13	Gold(III) bis-thiosemicarbazonato complexes: synthesis, characterization, radiochemistry and X-ray crystal structure analysis 2009 ·Nuclear Medicine and Biology ·(unknown),Para Kan,(unknown),B. Ballard,Tammy L. Rold,Charles L. Barnes,Cathy Cutler,Timothy J. Hoffman,Mark Green,Silvia S. Jurisson	26
14	Development of an in vitro model for assessing the in vivo stability of lanthanide chelates 2001 ·Nuclear Medicine and Biology ·(unknown),Dangshe Ma,C. Higginbotham,Timothy J. Hoffman,A.R. Ketring,Cathy S. Cutler,Silvia S. Jurisson	60
15	Current and Potential Therapeutic Uses of Lanthanide Radioisotopes 2000 ·Cancer Biotherapy and Radiopharmaceuticals ·Cathy S. Cutler,Charles J. Smith,Gary J. Ehrhardt,(unknown),Silvia S. Jurisson,Edward Deutsch	73
16	In vivo evaluation of 99mTc/188Re-labeled linear alpha-melanocyte stimulating hormone analogs for specific melanoma targeting 1999 ·Nuclear Medicine and Biology ·Jianqing Chen,Michael F. Giblin,(unknown),Silvia S. Jurisson,Thomas P. Quinn	54
17	Rhodium-105 tetrathioether complexes: radiochemistry and initial biological evaluation 1999 ·Nuclear Medicine and Biology ·Niranjan Goswami,(unknown),Wynn A. Volkert,Roger Alberto,Walter Nef,Silvia S. Jurisson	14
18	An Rh-105 complex of tetrathiacyclohexadecane diol with potential for formulating bifunctional chelates 1996 ·Nuclear Medicine and Biology ·(unknown),Niranjan Goswami,Wynn A. Volkert,E. O. Schlemper,A.R. Ketring,Charles L. Barnes,Silvia S. Jurisson	25
19	[99mTc]teboroxime and [99mTc]Cl(DMG)3B2MP: Binding characteristics and metabolism of two [99mTc]BATOs in blood and tissues 1993 ·Nuclear Medicine and Biology ·Karen C. Rosenspire,William L. Rumsey,Silvia S. Jurisson,(unknown),Ramakrishna Narra	5
20	Direct analysis of whole blood by internal surface reversed-phase chromatography: an examination of the binding and metabolism of technetium dioxime complexes 1992 ·Journal of Chromatography B Biomedical Sciences and Applications ·Karen C. Rosenspire,(unknown),Silvia S. Jurisson,David P. Nowotnik,W.C. Eckelman,Adrian D. Nunn	4

About Silvia S. Jurisson

Silvia S. Jurisson is a scholar working on Radiology, Nuclear Medicine and Imaging, Inorganic Chemistry and Oncology, having authored 154 papers that have together received 5.1k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (101 papers), Medical Imaging Techniques and Applications (33 papers) and Medical Imaging and Pathology Studies (26 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (3.0k citations), Inorganic Chemistry (896 citations) and Oncology (1.6k citations). Silvia S. Jurisson has collaborated with scholars based in United States, India and Greece. Frequent co-authors include John D. Lydon, Timothy J. Hoffman, Dangshe Ma, Cathy S. Cutler, Douglas E. Berning, Wei Jia, Heather M. Hennkens, Thomas P. Quinn, Charles L. Barnes and Nebiat Sisay. Their work appears in journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact